Vanta Bioscience

Quarterly
Consolidated
ParticularsDec '21Dec '22Mar '23
Revenue0.002.830.63
Expenses0.007.160.92
EBITDA0.00-0.540.00
EBIT0.000.010.00
Profit Before Tax0.00-2.47-1.36
Net Profit0.00-2.56-1.36
Financial Ratios
Operating Profit Margin0.00%-19.15%-100.00%
Net Profit Margin0.00%-90.78%-215.87%
Earning Per Share (Diluted)0.00-4.060.00
Dividends Per Share0.000.000.00